Intelligent
-
LG PRESENTS "LIVE BEYOND" WITH EXPANDED SECOND-GENERATION LG SIGNATURE LINEUP AT CES 2025Details
Showcasing the Evolution of the Company\'s Ultra-Premium Brand,Advanced Lineup Delivers Enhanced User Experiences and Enriched,Connected Living
-
Lichen China Limited Announces $3.1 Million Registered Direct OfferingDetails
XIAMEN,China,Dec. 30,2024--Lichen China Limited (Nasdaq: LICN)("Lichen China" or the "Company"),a dedicated financial and taxation service provider inChina today announced that it
-
Airoha Technology Launches Latest Flagship Wireless AI Audio SoC AB1595Details
Customer\'s Product to Hit the Market in Q1 2025 Enhancing Consumer Headset Speech Quality to Professional Grade
-
Seizing trends, shouldering responsibilities, and pursuing the greater goodDetails
BEIJING,Dec. 30,2024-- A report from People\'s Daily:International scholars have described the current global issues as a "multipronged mixed crisis." The Ukraine crisis,the ongoing Israel-P
-
U.S.-based LifeWave Celebrates 20x Growth in 5 Years with New Kaohsiung Branch OpeningDetails
TAIPEI,Dec. 30,2024-- Post-pandemic,global economies have faced numerous challenges. Yet,one company has defied the odds,achieving an astonishing 20-fold global revenue growth in just five years—from
-
CapitaLand Investment advances Sustainability leadership in 2024 by progressing toward decarbonisation milestones and recognition in leading global indexesDetails
13th consecutive year on the Dow Jones Sustainability World Index and 16th straight year on the Asia Pacific Index,following MSCI,FTSE4Good and GRESB accolades
-
EZGO Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyDetails
CHANGZHOU,China,Jan. 1,2025-- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"),a leading short-distance transportation solutions provider in China,today announced th
-
ATFX 2024 Recap: A Year of Expansion, Innovation, and Global LeadershipDetails
HONG KONG,Jan. 2,2025-- As 2024 concludes,ATFX has reinforced its position as a global leader in financial services,marking significant milestones across multiple areas. The company expanded its footp
-
FDA Grants Orphan Drug Designation to MicuRx's MRX-5 for NTM InfectionsDetails
SHANGHAI,Jan. 2,2025-- Shanghai MicuRx Pharmaceutical Co.,Ltd. ("MicuRx",688373.SH) announced that MRX-5,its self-developed anti-infection drug,has been granted Orphan Drug Designation (ODD
-
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044Details
WUHAN,China,Jan. 3,2025-- Hanx Biopharmaceuticals,CO. Ltd,an innovative biotechnology company developing next-generation immunotherapies to address the challenges of unmet medical need diseases,today